MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with F

Folinic acid

Calcium folinate 15mg tablets

No stability information

Stability notes for Calcium folinate 15mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Calcium folinate 15mg tablets
Calcium folinate 15mg tablets (A A H Pharmaceuticals Ltd)
Calcium folinate 15mg tablets (Alliance Healthcare (Distribution) Ltd)
Calcium folinate 15mg tablets (Medihealth (Northern) Ltd)
Calcium folinate 15mg tablets (Pfizer Ltd)
Calcium folinate 15mg tablets (Sigma Pharmaceuticals Plc)
Calcium folinate 15mg tablets (Teva UK Ltd)
Refolinon 15mg tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.